IN8BIO, Inc.
INABNasdaqCIK 1740279HealthcareFiscal year ends Dec 31
Income statement
| Line item | Unit | Q3 FY20232023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | $k | 3,786Research and development, Q3 FY2023, three months to 2023-09-30$3.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125537.Report this figure | 4,522Research and development, Q4 FY2023, three months to 2023-12-31$4.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-13, accession 0000950170-25-038738. Derived: 12-month figure less the 9-month figure.Report this figure | 4,903Research and development, Q1 FY2024, three months to 2024-03-31$4.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-07, accession 0000950170-25-065609.Report this figure | 5,156Research and development, Q2 FY2024, three months to 2024-06-30$5.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105028.Report this figure | 3,309Research and development, Q3 FY2024, three months to 2024-09-30$3.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269447.Report this figure | 3,594Research and development, Q4 FY2024, three months to 2024-12-31$3.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001193125-26-104181. Derived: 12-month figure less the 9-month figure.Report this figure | 2,972Research and development, Q1 FY2025, three months to 2025-03-31$3.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-212135.Report this figure | 2,487Research and development, Q2 FY2025, three months to 2025-06-30$2.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure | 2,104Research and development, Q3 FY2025, three months to 2025-09-30$2.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269447.Report this figure | 2,648Research and development, Q4 FY2025, three months to 2025-12-31$2.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001193125-26-104181. Derived: 12-month figure less the 9-month figure.Report this figure | 2,613Research and development, Q1 FY2026, three months to 2026-03-31$2.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-212135.Report this figure | 2,493Research and development, Q2 FY2026, three months to 2026-06-30$2.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure |
| Operating income | $k | (7,169)Operating income, Q3 FY2023, three months to 2023-09-30−$7.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125537.Report this figure | (7,598)Operating income, Q4 FY2023, three months to 2023-12-31−$7.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-13, accession 0000950170-25-038738. Derived: 12-month figure less the 9-month figure.Report this figure | (8,562)Operating income, Q1 FY2024, three months to 2024-03-31−$8.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-07, accession 0000950170-25-065609.Report this figure | (8,629)Operating income, Q2 FY2024, three months to 2024-06-30−$8.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105028.Report this figure | (7,086)Operating income, Q3 FY2024, three months to 2024-09-30−$7.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269447.Report this figure | (6,160)Operating income, Q4 FY2024, three months to 2024-12-31−$6.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-104181. Derived: 12-month figure less the 9-month figure.Report this figure | (5,550)Operating income, Q1 FY2025, three months to 2025-03-31−$5.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212135.Report this figure | (5,094)Operating income, Q2 FY2025, three months to 2025-06-30−$5.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure | (3,854)Operating income, Q3 FY2025, three months to 2025-09-30−$3.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269447.Report this figure | (4,942)Operating income, Q4 FY2025, three months to 2025-12-31−$4.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-104181. Derived: 12-month figure less the 9-month figure.Report this figure | (5,090)Operating income, Q1 FY2026, three months to 2026-03-31−$5.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212135.Report this figure | (4,781)Operating income, Q2 FY2026, three months to 2026-06-30−$4.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure |
| Income tax | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | (7,169)Net income, Q3 FY2023, three months to 2023-09-30−$7.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125537.Report this figure | (7,598)Net income, Q4 FY2023, three months to 2023-12-31−$7.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-13, accession 0000950170-25-038738. Derived: 12-month figure less the 9-month figure.Report this figure | (8,562)Net income, Q1 FY2024, three months to 2024-03-31−$8.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269447.Report this figure | (8,629)Net income, Q2 FY2024, three months to 2024-06-30−$8.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269447.Report this figure | (7,086)Net income, Q3 FY2024, three months to 2024-09-30−$7.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269447.Report this figure | (6,160)Net income, Q4 FY2024, three months to 2024-12-31−$6.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-104181. Derived: 12-month figure less the 9-month figure.Report this figure | (5,550)Net income, Q1 FY2025, three months to 2025-03-31−$5.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure | (5,094)Net income, Q2 FY2025, three months to 2025-06-30−$5.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure | (3,854)Net income, Q3 FY2025, three months to 2025-09-30−$3.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269447.Report this figure | (4,942)Net income, Q4 FY2025, three months to 2025-12-31−$4.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-104181. Derived: 12-month figure less the 9-month figure.Report this figure | (5,090)Net income, Q1 FY2026, three months to 2026-03-31−$5.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure | (4,781)Net income, Q2 FY2026, three months to 2026-06-30−$4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure |
| Diluted EPS | $ per share | (0.23)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-125537.Report this figure | not reported | (0.20)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-07, accession 0000950170-25-065609.Report this figure | (5.51)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$5.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-105028.Report this figure | (4.49)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$4.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269447.Report this figure | not reported | (2.16)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$2.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-212135.Report this figure | (1.24)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure | (0.85)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.85 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269447.Report this figure | not reported | (0.26)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-212135.Report this figure | (0.25)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure |
| Basic EPS | $ per share | (0.23)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-125537.Report this figure | not reported | (0.20)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-07, accession 0000950170-25-065609.Report this figure | (5.51)Basic EPS, Q2 FY2024, three months to 2024-06-30−$5.51 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-105028.Report this figure | (4.49)Basic EPS, Q3 FY2024, three months to 2024-09-30−$4.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269447.Report this figure | not reported | (2.16)Basic EPS, Q1 FY2025, three months to 2025-03-31−$2.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-212135.Report this figure | (1.24)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure | (0.85)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.85 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269447.Report this figure | not reported | (0.26)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-212135.Report this figure | (0.25)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure |
Balance sheet
| Line item | Unit | Q3 FY20232023-09-30 | FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $m | 12.9Cash and equivalents, Q3 FY2023, at 2023-09-30$12.9m. XBRL concept us-gaap:Cash. 10-Q filed 2024-11-12, accession 0000950170-24-125537.Report this figure | 21.3Cash and equivalents, FY2023, at 2023-12-31$21.3m. XBRL concept us-gaap:Cash. 10-K filed 2025-03-13, accession 0000950170-25-038738.Report this figure | 13.0Cash and equivalents, Q1 FY2024, at 2024-03-31$13.0m. XBRL concept us-gaap:Cash. 10-Q filed 2025-05-07, accession 0000950170-25-065609.Report this figure | 10.2Cash and equivalents, Q2 FY2024, at 2024-06-30$10.2m. XBRL concept us-gaap:Cash. 10-Q filed 2025-08-07, accession 0000950170-25-105028.Report this figure | 4.0Cash and equivalents, Q3 FY2024, at 2024-09-30$4.0m. XBRL concept us-gaap:Cash. 10-Q filed 2025-11-06, accession 0001193125-25-269447.Report this figure | 11.1Cash and equivalents, FY2024, at 2024-12-31$11.1m. XBRL concept us-gaap:Cash. 10-K filed 2026-03-12, accession 0001193125-26-104181.Report this figure | 11.9Cash and equivalents, Q1 FY2025, at 2025-03-31$11.9m. XBRL concept us-gaap:Cash. 10-Q filed 2026-05-07, accession 0001193125-26-212135.Report this figure | 13.2Cash and equivalents, Q2 FY2025, at 2025-06-30$13.2m. XBRL concept us-gaap:Cash. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure | 10.7Cash and equivalents, Q3 FY2025, at 2025-09-30$10.7m. XBRL concept us-gaap:Cash. 10-Q filed 2025-11-06, accession 0001193125-25-269447.Report this figure | 27.1Cash and equivalents, FY2025, at 2025-12-31$27.1m. XBRL concept us-gaap:Cash. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure | 21.9Cash and equivalents, Q1 FY2026, at 2026-03-31$21.9m. XBRL concept us-gaap:Cash. 10-Q filed 2026-05-07, accession 0001193125-26-212135.Report this figure | 18.0Cash and equivalents, Q2 FY2026, at 2026-06-30$18.0m. XBRL concept us-gaap:Cash. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure |
| Current assets | $m | 16.5Current assets, Q3 FY2023, at 2023-09-30$16.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062018.Report this figure | 24.6Current assets, FY2023, at 2023-12-31$24.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-13, accession 0000950170-25-038738.Report this figure | not reported | 12.7Current assets, Q2 FY2024, at 2024-06-30$12.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093943.Report this figure | 6.7Current assets, Q3 FY2024, at 2024-09-30$6.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125537.Report this figure | 12.6Current assets, FY2024, at 2024-12-31$12.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-12, accession 0001193125-26-104181.Report this figure | 12.7Current assets, Q1 FY2025, at 2025-03-31$12.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-07, accession 0000950170-25-065609.Report this figure | 13.7Current assets, Q2 FY2025, at 2025-06-30$13.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105028.Report this figure | 11.8Current assets, Q3 FY2025, at 2025-09-30$11.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269447.Report this figure | 27.9Current assets, FY2025, at 2025-12-31$27.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure | 22.7Current assets, Q1 FY2026, at 2026-03-31$22.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-212135.Report this figure | 18.5Current assets, Q2 FY2026, at 2026-06-30$18.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure |
| Total assets | $m | 26.2Total assets, Q3 FY2023, at 2023-09-30$26.2m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-062018.Report this figure | 33.7Total assets, FY2023, at 2023-12-31$33.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-13, accession 0000950170-25-038738.Report this figure | not reported | 22.5Total assets, Q2 FY2024, at 2024-06-30$22.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-093943.Report this figure | 16.0Total assets, Q3 FY2024, at 2024-09-30$16.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-125537.Report this figure | 20.9Total assets, FY2024, at 2024-12-31$20.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-12, accession 0001193125-26-104181.Report this figure | 19.9Total assets, Q1 FY2025, at 2025-03-31$19.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-07, accession 0000950170-25-065609.Report this figure | 19.4Total assets, Q2 FY2025, at 2025-06-30$19.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-105028.Report this figure | 16.8Total assets, Q3 FY2025, at 2025-09-30$16.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-269447.Report this figure | 32.3Total assets, FY2025, at 2025-12-31$32.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure | 26.3Total assets, Q1 FY2026, at 2026-03-31$26.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-212135.Report this figure | 21.7Total assets, Q2 FY2026, at 2026-06-30$21.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure |
| Current liabilities | $m | 4.7Current liabilities, Q3 FY2023, at 2023-09-30$4.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062018.Report this figure | 5.4Current liabilities, FY2023, at 2023-12-31$5.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-13, accession 0000950170-25-038738.Report this figure | not reported | 4.8Current liabilities, Q2 FY2024, at 2024-06-30$4.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093943.Report this figure | 3.6Current liabilities, Q3 FY2024, at 2024-09-30$3.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125537.Report this figure | 3.1Current liabilities, FY2024, at 2024-12-31$3.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-12, accession 0001193125-26-104181.Report this figure | 3.0Current liabilities, Q1 FY2025, at 2025-03-31$3.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-07, accession 0000950170-25-065609.Report this figure | 2.0Current liabilities, Q2 FY2025, at 2025-06-30$2.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105028.Report this figure | 1.7Current liabilities, Q3 FY2025, at 2025-09-30$1.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269447.Report this figure | 3.2Current liabilities, FY2025, at 2025-12-31$3.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure | 2.2Current liabilities, Q1 FY2026, at 2026-03-31$2.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-212135.Report this figure | 2.3Current liabilities, Q2 FY2026, at 2026-06-30$2.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure |
| Total liabilities | $m | 8.5Total liabilities, Q3 FY2023, at 2023-09-30$8.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000950170-23-062018.Report this figure | 8.8Total liabilities, FY2023, at 2023-12-31$8.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-13, accession 0000950170-25-038738.Report this figure | not reported | 8.9Total liabilities, Q2 FY2024, at 2024-06-30$8.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-093943.Report this figure | 7.4Total liabilities, Q3 FY2024, at 2024-09-30$7.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-125537.Report this figure | 6.5Total liabilities, FY2024, at 2024-12-31$6.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-12, accession 0001193125-26-104181.Report this figure | 6.0Total liabilities, Q1 FY2025, at 2025-03-31$6.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-07, accession 0000950170-25-065609.Report this figure | 4.1Total liabilities, Q2 FY2025, at 2025-06-30$4.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-105028.Report this figure | 3.6Total liabilities, Q3 FY2025, at 2025-09-30$3.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-269447.Report this figure | 4.7Total liabilities, FY2025, at 2025-12-31$4.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure | 3.5Total liabilities, Q1 FY2026, at 2026-03-31$3.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-212135.Report this figure | 3.4Total liabilities, Q2 FY2026, at 2026-06-30$3.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure |
| Shareholders' equity | $m | 17.8Shareholders' equity, Q3 FY2023, at 2023-09-30$17.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-125537.Report this figure | 24.9Shareholders' equity, FY2023, at 2023-12-31$24.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-12, accession 0001193125-26-104181.Report this figure | 17.5Shareholders' equity, Q1 FY2024, at 2024-03-31$17.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269447.Report this figure | 13.6Shareholders' equity, Q2 FY2024, at 2024-06-30$13.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269447.Report this figure | 8.6Shareholders' equity, Q3 FY2024, at 2024-09-30$8.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269447.Report this figure | 14.5Shareholders' equity, FY2024, at 2024-12-31$14.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure | 13.9Shareholders' equity, Q1 FY2025, at 2025-03-31$13.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure | 15.2Shareholders' equity, Q2 FY2025, at 2025-06-30$15.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure | 13.2Shareholders' equity, Q3 FY2025, at 2025-09-30$13.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269447.Report this figure | 27.6Shareholders' equity, FY2025, at 2025-12-31$27.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure | 22.8Shareholders' equity, Q1 FY2026, at 2026-03-31$22.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure | 18.4Shareholders' equity, Q2 FY2026, at 2026-06-30$18.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338012.Report this figure |
Cash flow
| Line item | Unit | Q3 FY20232023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $k | (5,713)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$5.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-125537. Derived: 9-month figure less the 6-month figure.Report this figure | (4,850)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$4.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-13, accession 0000950170-25-038738. Derived: 12-month figure less the 9-month figure.Report this figure | (7,919)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$7.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-07, accession 0000950170-25-065609.Report this figure | (6,091)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$6.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-105028. Derived: 6-month figure less the 3-month figure.Report this figure | (6,111)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$6.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269447. Derived: 9-month figure less the 6-month figure.Report this figure | (4,028)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001193125-26-104181. Derived: 12-month figure less the 9-month figure.Report this figure | (3,122)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-212135.Report this figure | (3,927)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338012. Derived: 6-month figure less the 3-month figure.Report this figure | (3,524)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$3.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269447. Derived: 9-month figure less the 6-month figure.Report this figure | (2,139)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$2.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001193125-26-104181. Derived: 12-month figure less the 9-month figure.Report this figure | (4,947)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$4.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-212135.Report this figure | (3,745)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$3.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338012. Derived: 6-month figure less the 3-month figure.Report this figure |
| Capital expenditure | $k | 0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0000950170-24-125537. Derived: 9-month figure less the 6-month figure.Report this figure | not reported | 50.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$50.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-07, accession 0000950170-25-065609.Report this figure | 21.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$21.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-105028. Derived: 6-month figure less the 3-month figure.Report this figure | 0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269447. Derived: 9-month figure less the 6-month figure.Report this figure | not reported | 0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-07, accession 0000950170-25-065609.Report this figure | 0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-105028. Derived: 6-month figure less the 3-month figure.Report this figure | 0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269447. Derived: 9-month figure less the 6-month figure.Report this figure | not reported | not reported | not reported |
Shares
| Line item | Unit | Q3 FY20222022-09-30 | Q1 FY20232023-03-31 | Q2 FY20232023-06-30 | Q3 FY20232023-09-30 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted shares (weighted) | m shares | 21.7 | 24.7 | 28.5 | 31.5 | 43.3 | 1.6 | 1.6 | 2.6 | 4.1 | 4.5 | 19.5 | 19.5 |
Shares outstanding: 9.86m at Aug 3, 2026, from the cover of the 10-Q filed Aug 6, 2026.
Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.